These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 28379057)

  • 1. Metoclopramide nasal spray in vitro evaluation and in vivo pharmacokinetic studies in dogs.
    Li Y; Fan X; Li W; Yang P; Zhang H; Tang D; Yin X; Sun J; Zheng A
    Pharm Dev Technol; 2018 Mar; 23(3):275-281. PubMed ID: 28379057
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid-onset intranasal delivery of metoclopramide hydrochloride Part II: Safety of various absorption enhancers and pharmacokinetic evaluation.
    Zaki NM; Mortada ND; Awad GA; Abd ElHady SS
    Int J Pharm; 2006 Dec; 327(1-2):97-103. PubMed ID: 16959453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In situ gels of Metoclopramide Hydrochloride for intranasal delivery: in vitro evaluation and in vivo pharmacokinetic study in rabbits.
    Mahajan HS; Gattani S
    Drug Deliv; 2010 Jan; 17(1):19-27. PubMed ID: 19958151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nasal administration of metoclopramide from different dosage forms: in vitro, ex vivo, and in vivo evaluation.
    Tas C; Ozkan CK; Savaser A; Ozkan Y; Tasdemir U; Altunay H
    Drug Deliv; 2009 Apr; 16(3):167-75. PubMed ID: 19514977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid-onset intranasal delivery of metoclopramide hydrochloride. Part I. Influence of formulation variables on drug absorption in anesthetized rats.
    Zaki NM; Awad GA; Mortada ND; Abd ElHady SS
    Int J Pharm; 2006 Dec; 327(1-2):89-96. PubMed ID: 16942844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced bioavailability of metoclopramide HCl by intranasal administration of a mucoadhesive in situ gel with modulated rheological and mucociliary transport properties.
    Zaki NM; Awad GA; Mortada ND; Abd Elhady SS
    Eur J Pharm Sci; 2007 Dec; 32(4-5):296-307. PubMed ID: 17920822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mucoadhesive microspheres for nasal administration of an antiemetic drug, metoclopramide: in-vitro/ex-vivo studies.
    Gavini E; Rassu G; Sanna V; Cossu M; Giunchedi P
    J Pharm Pharmacol; 2005 Mar; 57(3):287-94. PubMed ID: 15807983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nasal absorption of metoclopramide from different Carbopol 981 based formulations: In vitro, ex vivo and in vivo evaluation.
    Tas C; Ozkan CK; Savaser A; Ozkan Y; Tasdemir U; Altunay H
    Eur J Pharm Biopharm; 2006 Oct; 64(2):246-54. PubMed ID: 16870409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetic interaction between butorphanol nasal spray and oral metoclopramide in healthy women.
    Vachharajani NN; Shyu WC; Barbhaiya RH
    J Clin Pharmacol; 1997 Oct; 37(10):979-85. PubMed ID: 9505990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metoclopramide Nasal Spray Reduces Symptoms of Gastroparesis in Women, but not Men, With Diabetes: Results of a Phase 2B Randomized Study.
    Parkman HP; Carlson MR; Gonyer D
    Clin Gastroenterol Hepatol; 2015 Jul; 13(7):1256-1263.e1. PubMed ID: 25576687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intranasal absorption of rizatriptan--in vivo pharmacokinetics and bioavailability study in humans.
    Chen J; Jiang XG; Jiang WM; Gao XL; Mei N
    Pharmazie; 2005 Jan; 60(1):39-41. PubMed ID: 15702515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Naloxone nasal spray - bioavailability and absorption pattern in a phase 1 study.
    Tylleskar I; Skulberg AK; Nilsen T; Skarra S; Dale O
    Tidsskr Nor Laegeforen; 2019 Sep; 139(13):. PubMed ID: 31556537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metoclopramide nasal spray is effective in symptoms of gastroparesis in diabetics compared to conventional oral tablet.
    Parkman HP; Carlson MR; Gonyer D
    Neurogastroenterol Motil; 2014 Apr; 26(4):521-8. PubMed ID: 24372829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and
    Wang D; Du Y; Zhang W; Han X; Zhang H; Wang Z; Liu N; Li M; Gao X; Zhuang X; Gao J; Zheng A
    Drug Deliv; 2021 Dec; 28(1):487-498. PubMed ID: 33657948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetic study of salvianolic acid A in beagle dog after oral administration by a liquid chromatography-mass spectrometry method: a study on bioavailability and dose proportionality.
    Sun J; Zhang L; Song J; Tian S; Huang C; Feng Z; Lv Y; Du G
    J Ethnopharmacol; 2013 Jul; 148(2):617-23. PubMed ID: 23707334
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro permeation of desmopressin across rabbit nasal mucosa from liquid nasal sprays: the enhancing effect of potassium sorbate.
    Bortolotti F; Balducci AG; Sonvico F; Russo P; Colombo G
    Eur J Pharm Sci; 2009 Apr; 37(1):36-42. PubMed ID: 19162181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics and bioavailability of metoclopramide nasal spray versus metoclopramide intravenous in healthy volunteers and cancer patients.
    Scaglione F; Scanni A; Tomirotti M; Dimaiuta M; Ferrari P; Fraschini F
    Arzneimittelforschung; 1993 Sep; 43(9):986-8. PubMed ID: 8240464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mucoadhesive thermoreversible formulation of metoclopramide for rectal administration: a promising strategy for potential management of chemotherapy-induced nausea and vomiting.
    El-Sonbaty MM; Ismail HR; Kassem AA; Samy AM; Akl MA
    Pharm Dev Technol; 2020 Jun; 25(5):535-546. PubMed ID: 31903824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative pharmacokinetics of nalbuphine nasal spray and solution for injection in healthy volunteers.
    Tymko VG; Tsapko GV; Kovalova KV; Mashchenko SV; Oliinykov DS; Kuznetsov IE
    Br J Clin Pharmacol; 2023 Nov; 89(11):3311-3323. PubMed ID: 37328144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative estimation of drug permeation through nasal mucosa using in vitro membrane permeability across Calu-3 cell layers for predicting in vivo bioavailability after intranasal administration to rats.
    Inoue D; Furubayashi T; Tanaka A; Sakane T; Sugano K
    Eur J Pharm Biopharm; 2020 Apr; 149():145-153. PubMed ID: 32057906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.